Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review

Dopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson’s disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Xiomara, Mohammad, Mohammad Edrees, Patel, Shnehal, Yu, Xin Xin, Fernandez, Hubert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335375/
https://www.ncbi.nlm.nih.gov/pubmed/35909701
http://dx.doi.org/10.1016/j.prdoa.2022.100153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335375/
https://www.ncbi.nlm.nih.gov/pubmed/35909701
http://dx.doi.org/10.1016/j.prdoa.2022.100153

Ejemplares similares